Retraction: MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.

Zhao N, Lin T, Zhao C, Zhao S, Zhou S, Li Y

DOI: 10.1002/jcb.26417
Published: 2017 Oct 5
Container: Journal of cellular biochemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcb.26417,
  title = {Retraction: MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.},
  author = {Zhao N and Lin T and Zhao C and Zhao S and Zhou S and Li Y},
  year = {2017},
  journal = {Journal of cellular biochemistry},
  doi = {10.1002/jcb.26417},
  url = {https://doi.org/10.1002/jcb.26417}
}

RIS

TY  - JOUR
TI  - Retraction: MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.
AU  - Zhao N
AU  - Lin T
AU  - Zhao C
AU  - Zhao S
AU  - Zhou S
AU  - Li Y
PY  - 2017
JO  - Journal of cellular biochemistry
DO  - 10.1002/jcb.26417
UR  - https://doi.org/10.1002/jcb.26417
ER  -

APA

N, Z., T, L., C, Z., S, Z., S, Z., & Y, L. (2017). Retraction: MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.. Journal of cellular biochemistry. https://doi.org/10.1002/jcb.26417

Source records

pubmed · retrieved 2026-09-25T02:27:59.279Z